Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Shakespeare

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Annals of Clinical and Laboratory Science|February 19, 2022
Prognostic Value of the Neutrophil-Lymphocyte Ratio in Triple Negative Breast Cancer PatientsKate Shi, Justin Westhuyzen, Aron Gortman, et al.
Journal of Medical Imaging and Radiation Oncology|September 15, 2019
Late toxicities of prostate cancer radiotherapy with and without hydrogel SpaceAOR insertionBridget L Te Velde, Justin Westhuyzen, Nader Awad, et al.
Journal of Medical Imaging and Radiation Oncology|February 3, 2017
Can a peri-rectal hydrogel spaceOAR programme for prostate cancer intensity-modulated radiotherapy be successfully implemented in a regional setting?Bridget L Te Velde, Justin Westhuyzen, Nader Awad, et al.
Journal of Medical Radiation Sciences|August 1, 2015
Regional cancer centre demonstrates voluntary conformity with the national Radiation Oncology Practice StandardsStephen Manley, Andrew Last, Kenneth Fu, et al.
The Laryngoscope|May 4, 2005
Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicityJiade Jay Lu, Thomas P Shakespeare, Anu Thiagarajan, et al.
Breast Cancer (Dove Medical Press)|March 19, 2020
Effect of Clinical and Treatment Factors on Survival Outcomes of Triple Negative Breast Cancer PatientsShelly Wen, Lucy Manuel, Moira Doolan, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|October 5, 2022
Bone health assessment with dual energy X-ray absorptiometry in men with high-risk prostate carcinoma commencing adjuvant androgen deprivation therapyBelinda Pan, Noel J Aherne, Thomas P Shakespeare, et al.
Cureus|January 11, 2024
No Increase in Acute or Late Radiation Toxicities in Patients With Ehlers-Danlos Syndrome Receiving Adjuvant Breast Radiation Therapy: A Report of Four Cases With Extended Follow-UpMichael T Hsieh, Julan Amalaseelan, Abdul Rahim Mohd Tahir, et al.
Cureus|February 1, 2024
Long-Term Survival After Definitive Concurrent Chemoradiation Therapy for Synchronous Small Cell Neuroendocrine Carcinoma of the Urinary Bladder and Adenocarcinoma of the Prostate: A Case ReportMichael T Hsieh, Richard Tustin, Tue Le, et al.
Journal of Medical Imaging and Radiation Oncology|May 11, 2021
Equity should know no borders: The role of Australasian radiation oncologists in supporting radiation oncology services in low- and middle-income countries in the Asia-PacificSean Hassan, Andrew Oar, Iain Ward, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Annals of Clinical and Laboratory Science|February 19, 2022
Prognostic Value of the Neutrophil-Lymphocyte Ratio in Triple Negative Breast Cancer PatientsKate Shi, Justin Westhuyzen, Aron Gortman, et al.
Journal of Medical Imaging and Radiation Oncology|September 15, 2019
Late toxicities of prostate cancer radiotherapy with and without hydrogel SpaceAOR insertionBridget L Te Velde, Justin Westhuyzen, Nader Awad, et al.
Journal of Medical Imaging and Radiation Oncology|February 3, 2017
Can a peri-rectal hydrogel spaceOAR programme for prostate cancer intensity-modulated radiotherapy be successfully implemented in a regional setting?Bridget L Te Velde, Justin Westhuyzen, Nader Awad, et al.
Journal of Medical Radiation Sciences|August 1, 2015
Regional cancer centre demonstrates voluntary conformity with the national Radiation Oncology Practice StandardsStephen Manley, Andrew Last, Kenneth Fu, et al.
The Laryngoscope|May 4, 2005
Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicityJiade Jay Lu, Thomas P Shakespeare, Anu Thiagarajan, et al.
Breast Cancer (Dove Medical Press)|March 19, 2020
Effect of Clinical and Treatment Factors on Survival Outcomes of Triple Negative Breast Cancer PatientsShelly Wen, Lucy Manuel, Moira Doolan, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|October 5, 2022
Bone health assessment with dual energy X-ray absorptiometry in men with high-risk prostate carcinoma commencing adjuvant androgen deprivation therapyBelinda Pan, Noel J Aherne, Thomas P Shakespeare, et al.
Cureus|January 11, 2024
No Increase in Acute or Late Radiation Toxicities in Patients With Ehlers-Danlos Syndrome Receiving Adjuvant Breast Radiation Therapy: A Report of Four Cases With Extended Follow-UpMichael T Hsieh, Julan Amalaseelan, Abdul Rahim Mohd Tahir, et al.
Cureus|February 1, 2024
Long-Term Survival After Definitive Concurrent Chemoradiation Therapy for Synchronous Small Cell Neuroendocrine Carcinoma of the Urinary Bladder and Adenocarcinoma of the Prostate: A Case ReportMichael T Hsieh, Richard Tustin, Tue Le, et al.
Journal of Medical Imaging and Radiation Oncology|May 11, 2021
Equity should know no borders: The role of Australasian radiation oncologists in supporting radiation oncology services in low- and middle-income countries in the Asia-PacificSean Hassan, Andrew Oar, Iain Ward, et al.
Pageof 6